AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MAPS

M&A Activity May 9, 2022

4072_rf_2022-05-09_0cfaab25-85c4-482a-baa4-fbd9d473cdbe.pdf

M&A Activity

Open in Viewer

Opens in native device viewer

Informazione
Regolamentata n.
20153-25-2022
Data/Ora Ricezione
09 Maggio 2022
09:34:30
Euronext Growth Milan
Societa' : MAPS
Identificativo
Informazione
Regolamentata
: 161826
Nome utilizzatore : MAPSN03 - Ciscato
Tipologia : REGEM; 3.1
Data/Ora Ricezione : 09 Maggio 2022 09:34:30
Data/Ora Inizio
Diffusione presunta
: 09 Maggio 2022 09:34:31
Oggetto : MAPS: REGISTRATION OF THE DEED
OF MERGER BY INCORPORATION OF
MAPS HEALTHCARE S.R.L. IN ARTEXE
S.P.A.
Testo del comunicato

Vedi allegato.

MAPS: REGISTRATION OF THE DEED OF MERGER BY INCORPORATION OF MAPS HEALTHCARE S.R.L. IN ARTEXE S.P.A.

Parma, 09 May 2022

MAPS (MAPS:IM; IT0005364333), Innovative SME listed on Euronext Growth Milan active in the digital transformation sector, following what was communicated on 30 November 2021, 21 and 25 December 2022 and 07 April 2022, has announced that, on 1th May 2022, was the registration of the Deed of Merger by incorporation of Maps Healthcare S.r.l. into Artexe S.p.A (the "Merger") at the competent Register of Companies, pursuant to article 2504 of the Italian Civil Code.

The legal effectiveness of the Merger will take effect, as set forth in the Merger Deed, on 1 May 2021. The accounting effects set out in art. 2501-ter, paragraph 1, no. 6 of the Italian Civil Code, will start from the first day of the financial year during which the Merger was completed, pursuant to and for the purposes of

art. 2504-bis, paragraph 2 of the Italian Civil Code and, therefore, from that date, the accounting operations of the Company to be incorporated will be posted to the financial statements of the Merging Company.

The tax effects of the Merger will also take effect from the date on which it becomes effective for accounting purposes, i.e. from the first day of the financial year in which the Merger was completed, pursuant to art. 172, paragraph 9 of Presidential Decree 917/86.

For a more detailed description of the terms of the Merger, reference should be made to the press releases and other documents filed and made public at the Company's registered office and on the website www.mapsgroup.it, Investors/Mergers section.

MAPS GROUP

Founded in 2002, MAPS is an Innovative SME operating in the digital transformation sector. With its registered office in Parma and with approximately 200 employees, it produces and distributes software for the analysis of big data that allows client companies to manage and analyse large quantities of data and information, helping them make strategic and operational decisions and define new business models. Operating in a context characterised by high growth potential: investments in digital transformation estimated for the three-year period 2022-2024 are approximately \$6.3 billion with a CAGR of 16.5% (Source: IDC). MAPS operates through three business units focused respectively on the Health, Energy and Sustainability (ESG) sectors, providing solutions to a portfolio of over 500 highly loyal customers. Through its Patient Journey product line, MAPS is positioned as a leader in the field of patient reception in healthcare facilities, presiding over the market with over 1,500 installations, managing 36 million patient admissions nationwide. Thanks to ROSE, an intelligent energy management platform, MAPS now supports the main trends in the energy transition leading to the emergence of new business models based on flexibility, such as the energy communities. In terms of sustainability, GZOOM's value governance solution is now used by over 70 Italian organisations to measure objectives, manage risks, and share their non-financial performance. The Group is investing on an ongoing basis in R&D: in the last 3 years it has allocated a total of €5.3 million to innovation. The Research & Solutions division, set up in 2016, is responsible for identifying market needs and evolving software solutions.

The Group closes 2021 with consolidated revenues of €21.5 million (+20% compared to 2020) - with significant growth in revenues from Healthcare (+62%) and ESG (+69%) markets - and EBITDA of €5 million (23.3% EBITDA Margin). In the last three years MAPS has more than tripled its revenues from its proprietary solutions (15.2 million in 2021, or 72% of consolidated revenues). The company is characterised by high levels of recurring revenues: recurring fee revenues reached 34% of consolidated operating revenues in 2021 (CAGR 2018-2021 of 38%). The Group's organic growth has been accompanied by significant M&A activity, with the acquisition of IG Consulting (2011), Artexe (2018), Roialty (2019), SCS Computers (2020), IASI (2021) and I-TEL (2022).

Release available on and on www.mapsgroup.it

CONTACTS

MAPS T +390521052300 [email protected]

Marco Ciscato – Investor Relations Manager

[email protected]

EURONEXT GROWTH ADVISOR BPER Banca | T +390272 74 92 29 [email protected]

INVESTOR RELATIONS & FINANCIAL MEDIA IR Top Consulting | T +390245473884 Maria Antonietta Pireddu, [email protected] Domenico Gentile, [email protected] │ Antonio Buozzi, [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.